
The acquisition brings Gallant’s experimental stem cell treatments for feline chronic gingivostomatitis and osteoarthritis in dogs and cats into Dechra’s portfolio.
Not everyone is good at everything. Here's how to get additional team members on board with training others
Not everyone is good at everything. Here's how to get additional team members on board with training others.


